Steven Schnittman

3.0k total citations · 1 hit paper
22 papers, 2.2k citations indexed

About

Steven Schnittman is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Steven Schnittman has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 17 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Steven Schnittman's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (10 papers). Steven Schnittman is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (10 papers). Steven Schnittman collaborates with scholars based in United States, South Africa and Italy. Steven Schnittman's co-authors include H. Clifford Lane, Anthony S. Fauci, Cecil H. Fox, Norman P. Salzman, Miltiades C. Psallidopoulos, F Massari, Michael Baseler, Thomas M. Folks, Peter J. Piliero and Anthony S. Fauci and has published in prestigious journals such as Science, Nature Medicine and Annals of Internal Medicine.

In The Last Decade

Steven Schnittman

21 papers receiving 2.2k citations

Hit Papers

The Reservoir for HIV-1 in Human Peripheral Blood Is a T ... 1989 2026 2001 2013 1989 200 400 600

Peers

Steven Schnittman
Jo Ann M. Mican United States
Catherine Rehm United States
Stephanie B. Mizell United States
Maarten Koot Netherlands
R E de Goede Netherlands
Steven Schnittman
Citations per year, relative to Steven Schnittman Steven Schnittman (= 1×) peers Dominique Mathez

Countries citing papers authored by Steven Schnittman

Since Specialization
Citations

This map shows the geographic impact of Steven Schnittman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Schnittman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Schnittman more than expected).

Fields of papers citing papers by Steven Schnittman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Schnittman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Schnittman. The network helps show where Steven Schnittman may publish in the future.

Co-authorship network of co-authors of Steven Schnittman

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Schnittman. A scholar is included among the top collaborators of Steven Schnittman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Schnittman. Steven Schnittman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiser, Jennifer J., Richard M. Rutstein, Pearl Samson, et al.. (2011). Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents. AIDS. 25(12). 1489–1496. 17 indexed citations
2.
Gray, Glenda, et al.. (2006). Antiviral Activity of Nucleoside Analogues During Short-Course Monotherapy or Dual Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(2). 169–176. 12 indexed citations
4.
Sanne, Ian, Peter J. Piliero, Kathleen Squires, Alexandra Thiry, & Steven Schnittman. (2003). Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive Subjects. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(1). 18–29. 179 indexed citations
5.
Haas, David W., Carlos Zala, Shannon Schrader, et al.. (2003). Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial. AIDS. 17(9). 1339–1349. 78 indexed citations
6.
Haas, David W., Carlos Zala, Shannon Schrader, et al.. (2002). Atazanavir plus saquinavir once daily: favorable effects on lipid profiles in patients failing prior protease inhibitor therapy (trial AI424-009). Journal of the American College of Cardiology. 39. 227–227. 1 indexed citations
7.
Havlir, Diane V., Peter B. Gilbert, Kara Bennett, et al.. (2001). Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS. 15(11). 1379–1388. 62 indexed citations
8.
Dixon, Dennis O., et al.. (1999). Relationship Between Event Rates and Treatment Effects in Clinical Site Differences Within Multicenter Trials. Controlled Clinical Trials. 20(3). 253–266. 6 indexed citations
9.
Rhame, Frank S., Richard W. Price, David C. Perlman, et al.. (1998). Experience with a cross-study endpoint review committee for AIDS clinical trials. AIDS. 12(15). 1983–1990. 16 indexed citations
10.
Cohen, Oren J., Timothy W. Schacker, Mauro Vaccarezza, et al.. (1998). Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiviral therapy. Nature Medicine. 4(3). 341–345. 101 indexed citations
11.
Mayers, Douglas L., James Bethel, M A Wainberg, O. S. Weislow, & Steven Schnittman. (1998). Human Immunodeficiency Virus Proviral DNA from Peripheral Blood and Lymph Nodes Demonstrates Concordant Resistance Mutations to Zidovudine (Codon 215) and Didanosine (Codon 74). The Journal of Infectious Diseases. 177(6). 1730–1733. 8 indexed citations
13.
Maria, Andrea De, Sandra Colombini, Steven Schnittman, & Lorenzo Moretta. (1994). CD8+ cytolytic T lymphocytes become infected in vitro in the process of killing HIV‐1‐infected target cells. European Journal of Immunology. 24(3). 531–536. 19 indexed citations
14.
Schnittman, Steven, et al.. (1994). A Phase I Study of Interferon-α2b in Combination with Interleukin-2 in Patients with Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 169(5). 981–989. 25 indexed citations
15.
Niu, Manette T., et al.. (1993). Summary of the National Institutes of Health Workshop on Primary Human Immunodeficiency Virus Type 1 Infection 1,2. AIDS Research and Human Retroviruses. 9(9). 913–924. 22 indexed citations
16.
Schnittman, Steven, Jack Greenhouse, H. Clifford Lane, Phillip F. Pierce, & Anthony S. Fauci. (1991). Frequent Detection of HIV-1-Specific mRNAs in Infected Individuals Suggests Ongoing Active Viral Expression in All Stages of Disease. AIDS Research and Human Retroviruses. 7(4). 361–367. 86 indexed citations
17.
Fauci, Anthony S., Steven Schnittman, Guido Poli, Scott Koenig, & Giuseppe Pantaleo. (1991). Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection. Annals of Internal Medicine. 114(8). 678–693. 225 indexed citations
19.
Schnittman, Steven, et al.. (1988). Host defense againstMycobacterium-avium complex. Journal of Clinical Immunology. 8(4). 234–243. 42 indexed citations
20.
Schnittman, Steven, et al.. (1986). Direct Polyclonal Activation of Human B Lymphocytes by the Acquired Immune Deficiency Syndrome Virus. Science. 233(4768). 1084–1086. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026